Skip to main content
mSystems logoLink to mSystems
. 2021 Mar 9;6(2):e01302-20. doi: 10.1128/mSystems.01302-20

Tonsillar Microbiota: a Cross-Sectional Study of Patients with Chronic Tonsillitis or Tonsillar Hypertrophy

Shengru Wu a, Lalle Hammarstedt-Nordenvall b,c, Mattias Jangard d, Liqin Cheng a, Sebastian Alexandru Radu a, Pia Angelidou a, Yinghua Zha a, Marica Hamsten a, Lars Engstrand a, Juan Du a,✉,#, Anders Ternhag e,f,#
Editor: Naseer Sangwang
PMCID: PMC8547005  PMID: 33688019

ABSTRACT

Chronic tonsillitis (CT) and tonsillar hypertrophy (TH) are common tonsillar diseases that are related to infection and inflammation. Little is known about tonsillar microbiota and its role in CT and TH. This study aims to identify palatine tonsillar microbiota both on the surface and in the core tissues of CT and TH patients. In total, 22 palatine tonsils were removed and collected from CT and TH patients who underwent surgery. The surface and core microbiota in the tonsils of CT and TH patients were compared using 16S rRNA gene sequencing of V3-V4 regions. Differential tonsillar microbiotas were found in the CT versus TH patients and surface versus core tissues. Further, a higher relative abundance of bacterial genera, including Haemophilus, Streptococcus, Neisseria, Capnocytophaga, Kingella, Moraxella, and Lachnospiraceae [G-2] in patients with TH and Dialister, Parvimonas, Bacteroidales [G-2], Aggregatibacter, and Atopobium in patients with CT, was observed. Of these, the differential genera of Dialister, Parvimonas, and Neisseria served as key factors in the tonsillar microbiota network. Notably, four representable tonsillar microbial types were identified, with one, consisting of a higher abundance of Haemophilus and Neisseria, exclusively detected in the TH patients. This study analyzed the different tonsillar microbiota from the surface and core tissues of CT and TH patients. Several bacteria and various microbial types related to CT and TH were identified, along with potential bacterial networks and related immune pathways.

IMPORTANCE The human microbiota has been shown to be functionally connected to infectious and inflammation-related diseases. So far, only limited studies had been performed on tonsillar microbiota, although tonsils play an essential role in the human immune defense system and encountered numerous microorganisms. Our work presented different tonsillar microbiota from surface and core tissues of chronic tonsillitis (CT) and tonsillar hypertrophy (TH) patients. Notably, one tonsillar microbiota type, which contains a higher abundance of Haemophilus and Neisseria, was only detected in the TH patients. Furthermore, certain bacteria, such as Haemophilus, Neisseria, Dialister, and Parvimonas, may serve as microbial biomarkers to discriminate CT patients from TH patients. These data provide important microbiota data in the tonsillar research area and are highly useful for researchers both in the oral microbiome field and clinical field.

KEYWORDS: chronic tonsillitis, tonsillar hypertrophy, tonsillar tissues, microbiota, 16S rRNA gene sequencing

INTRODUCTION

Palatine tonsils are important mucosa-associated and immunocompetent lymphoid organs located close to the respiratory and gastrointestinal tracts, which are teeming with microorganisms (1). The palatine tonsils could protect the body from the entry of exogenous material through mucosal sites. This condition also enables the passage of microorganisms through the epithelium, which attacks the immune system and causes tonsillar diseases (2). Chronic tonsillitis (CT) and tonsillar hypertrophy (TH), which lead to a sore throat or obstructive symptoms, including snoring and apnea, are the most common causes for tonsillectomy. CT is defined as a persistent and repetitive inflammation of the palatine tonsils and is characterized by infective symptoms (3). TH is more often accompanied by obstructive sleep apnea and no symptoms of infection (4). Although the clinical criteria for CT and TH have been published, the potential biomarkers to identify CT patients from TH patients and the pathogenesis behind the diseases are still under investigation (5).

So far, only a few microbiota studies have been performed on tonsils, especially tonsillar tissues, although they play an essential role in the human immune system and encounter numerous microorganisms all the time (1, 2, 68). Most of these studies were carried out using in vitro cultures of tonsillar bacteria (6, 7), but the culturing methods mostly ignored the less abundant or unculturable bacteria (6, 8). Other studies have used 16S rRNA gene sequencing with tonsillar swab samples, only considering surface microbiota (811). The composition of tonsillar microbiota may vary and play different roles in surface and core tonsillar tissues, and bacteria that cause tonsillitis may inhabit both the tonsillar surface and core tissue (6, 10). Identifying the differences between the tonsillar surface and the core tissue of the CT and TH patients provides detailed information on the potential development of the diseases from a microbiological perspective.

Thus, we aimed to identify the tonsillar microbiota both on the surface and in the core tissues of CT and TH patients using 16S rRNA gene sequencing of V3-V4 regions. Further comparison of the tonsillar microbiota of the four groups, namely, the core tonsil of chronic tonsillitis patients (C-CT), the surface tonsil of chronic tonsillitis patients (S-CT), the core tonsil of tonsillar hypertrophy patients (C-TH), and the surface tonsil of tonsillar hypertrophy patients (S-TH), was also carried out (see sample site in Fig. S1A in the supplemental material). This study provided a comprehensive view of tonsillar microbiota from both the core and surface tissues of CT and TH patients.

FIG S1

Comparison of tonsillar (core tonsil and surface tonsil) microbial alpha diversity (ACE and Chao1 indices) in chronic tonsillitis (CT) and tonsillar hypertrophy (TH) patients. (A) Image of a lanced tonsil. The core and surface tissue areas are shown with yellow dotted lines. The sample site from core tissue is presented with a red dotted line, and the sample site from surface tissue is presented with a blue dotted line. (B) The microbial alpha diversity (ACE and Chao1 indices) in CT and TH patients was compared. The Mann-Whitney U test was carried out for comparing the two groups. (B) The microbial alpha diversity (ACE and Chao1 indices) in four groups, the core tonsil of chronic tonsillitis patients (C-CT), the surface tonsil of chronic tonsillitis patients (S-CT), the core tonsil of tonsillar hypertrophy patients (C-TH), and the surface tonsil of tonsillar hypertrophy patients (S-TH), was compared. Kruskal-Wallis test with Dunn’s post hoc tests was performed to compare all the groups. All the data are presented as mean ± standard deviation (SD) OTU counts. *, p < 0.05. Download FIG S1, PDF file, 0.1 MB (130KB, pdf) .

Copyright © 2021 Wu et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

RESULTS

Differential microbiota diversity identified from the core and surface tonsils of CT and TH patients.

In total, 42 microbial DNA samples were successfully sequenced and used for further tonsillar microbiota analysis, including 10 samples of C-CT, 10 samples of S-CT, 10 samples of C-TH, and 12 samples of S-TH (Table 1). Two C-TH samples were excluded due to low library concentration.

TABLE 1.

Clinical characteristics of the patients who underwent tonsillectomy due to CT or TH

Patient no. Gender Disease Age (yr) Source of sequenced DNA samples
1 Male TH 2 Surface/core of left tonsil, surface of right tonsil
2 Male TH 7 Surface/core of left tonsil, surface/core of right tonsil
3 Female TH 5 Surface/core of left tonsil, surface of right tonsil
4 Missing CT 10 Surface/core of left tonsil, surface/core of right tonsil
5 Male TH 6 Surface/core of left tonsil, surface/core of right tonsil
6 Male CT 30 Surface/core of left tonsil, surface/core of right tonsil
7 Male TH 6 Surface/core of left tonsil, surface/core of right tonsil
8 Male CT 9 Surface/core of left tonsil, surface/core of right tonsil
9 Male CT 22 Surface/core of left tonsil, surface/core of right tonsil
10 Female CT 29 Surface/core of left tonsil, surface/core of right tonsil
11 Female TH 2 Surface/core of left tonsil, surface/core of right tonsil

First, microbial alpha diversity was tested using Simpson, abundance-based coverage estimator (ACE), and Chao1 indices. No significant differences in the microbial diversity were observed between CT and TH patients (Fig. 1A; see also Fig. S1B in the supplemental material). However, by further dividing the samples into four groups, C-CT, S-CT, C-TH, and S-TH, we found higher microbiota diversity (Simpson) in S-CT than C-TH and S-TH (Fig. 1B). Additionally, the Chao 1 and ACE indices showed higher microbial community richness in S-CT, C-TH, and S-TH than C-CT (Fig. S1C). Overall, the microbiota richness and diversity of each sample, although slightly different, with some reaching significant levels, were very similar, indicating a comparable alpha diversity of microbiome in tonsils.

FIG 1.

FIG 1

Comparison of tonsillar (core tonsil and surface tonsil) microbial alpha diversity (Simpson index) and beta diversity (nonmetric multidimensional scaling [NMDS] analysis with operational taxonomic units [OTU] based on Bray-Curtis distance matrix) between chronic tonsillitis (CT) and tonsillar hypertrophy (TH) patients. (A) The microbial alpha diversity was compared between the patient groups of CT and TH. The Mann-Whitney U test was carried out for comparing the two groups. (B) The microbial alpha diversity was compared between four groups, i.e., the core tonsil of chronic tonsillitis patients (C-CT), the surface tonsil of chronic tonsillitis patients (S-CT), the core tonsil of tonsillar hypertrophy patients (C-TH), and the surface tonsil of tonsillar hypertrophy patients (S-TH). Only S-CT was found to have significantly higher microbial alpha diversity than C-TH and S-TH. The Kruskal-Wallis test with Dunn’s post hoc test was performed to compare all the groups. (C) A significant difference in the microbial beta diversity was observed in the CT patients and TH patients. (D) Significant microbial beta diversity difference was seen in the C-CT, S-CT, C-TH, and S-TH groups. (E) The microbial beta diversity was compared between tissues collected from the core and surface tonsils of the CT patients, and no significant difference was observed. (F) The microbial beta diversity was compared between the tissues collected from the core and surface tonsils of TH patients, and no obvious difference was observed. (G) The microbial beta diversity was compared between the tissues collected from the core tonsils of the CT and TH patients, and a clear separation was seen. (H) The microbial beta diversity was significantly different between the tissues collected from the surface tonsils of the CT and TH patients. All the data in panels A and B are presented as means ± standard deviations (SD) from the OTU counts. *, p < 0.05. For panels C to H, ANOSIM test was performed for comparing different groups.

The comparison of microbiota beta diversity between CT and TH patients through nonmetric multidimensional scaling (NMDS) analysis based on the identified operational taxonomic units (OTUs) presented a significant dissimilarity (pANOSIM [analysis of similarity] = 0.001) (Fig. 1C). Further, a significant level of separation (pANOSIM = 0.001) was also observed when the patients were assigned to the C-CT, S-CT, C-TH, and S-TH groups (Fig. 1D). The microbiota from the core and surface tonsillar tissues of the same disease type were found to be similar (Fig. 1E and F). Notably, both the core and surface tonsillar microbiota could be used to distinguish the CT patients from the TH patients (pANOSIM = 0.010 and 0.006) (Fig. 1G and H). Furthermore, although age and gender influence microbiota diversity, by excluding the potential interferences from age and gender, significant dissimilarity of microbiota was still observed (Table S1). Overall, the tonsillar microbial communities significantly differ in the CT and TH patient groups.

TABLE S1

Different microbial composition of core or surface tonsils from chronic tonsillitis (CT) or tonsillar hypertrophy (TH) patients based on a permutational multivariate analysis of variance (PERMANOVA). Download Table S1, DOCX file, 0.02 MB (20.6KB, docx) .

Copyright © 2021 Wu et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Genera and species composition identified from the surface and core tonsils of CT and TH patients.

A total of 118 genera and 256 species were identified in all the tonsillar samples (Fig. 2 and Fig. S2). The top four main genera that were found in the tonsil samples were Fusobacterium, Haemophilus, Streptococcus, and Prevotella (Fig. 2A and B). Of the 118 genera, 17 and 4 genera were identified only in CT and TH patients, respectively (Fig. 2C). Ten genera were identified in only one of the four groups (C-CT, S-CT, C-TH, and S-TH) (Fig. 2C). Among the 256 species, Fusobacterium nucleatum subsp. vincentii, Haemophilus influenzae, Dialister invisus, and Parvimonas micra were the top defined species that were detected in tonsillar tissues from both CT and TH patients (Fig. S2). Moreover, the Bacteroidales [G-2] bacterium HMT 274 and Streptococcus pyogenes were identified as the most abundant species that were detected only in the CT and TH patients, respectively (Fig. S2).

FIG 2.

FIG 2

Microbial composition at the genus level in CT and TH patients. (A) The microbial genus composition was compared between the patient groups of CT and TH. (B) The microbial genus composition was compared between the C-CT, S-CT, C-TH, and S-TH groups. (C) The unique and common genera between the C-CT, S-CT, C-TH, and S-TH groups. Total genus numbers detected in each group are listed below. Only genera with relative abundance of more than 1% are listed in panels A and B.

FIG S2

Comparison of the tonsillar (core tonsil and surface tonsil) microbial communities at the species level in CT and TH patients. (A) The microbial species in the CT and TH patients were compared. (B) The microbial species in the C-CT, S-CT, C-TH, and S-TH groups were compared. Only species abundance of more than 1% are listed in panels A and B. Download FIG S2, TIF file, 2.8 MB (2.8MB, tif) .

Copyright © 2021 Wu et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Four tonsillar microbial types identified.

According to the similarities in the genera identified from different samples, four different tonsillar microbial types were identified (Fig. 3A): type 1 has higher abundance of Fusobacterium, Dialister, and Prevotella, type 3 has higher abundance of Haemophilus and Neisseria, type 4 has higher abundance of Streptococcus and Gemella, and type 2 has an abundance similar to those of the abovementioned genera (Fig. 3B). Notably, type 3 was identified only in the TH patients (Fig. 3C). Further, type 4 was not detected in the S-TH group (Fig. 3D). These results were mainly due to the CT group not containing as abundant Haemophilus and Neisseria as the TH patients (Fig. 2A and 3A and B).

FIG 3.

FIG 3

Tonsillar microbial type distribution in tonsillar (core tonsil and surface tonsil) tissues from CT and TH patients using partitioning around medoids (PAM) clusters based on the Jensen-Shannon distance (JSD) and Calinski-Harabasz (CH) indices. (A) Four different tonsillar microbial types were identified based on the genera of tonsillar microbes from CT and TH patients. (B) The microbial genus composition was compared between four different tonsillar microbial types. Only genera with relative abundance of more than 1% are listed. (C) The microbial types distribution was compared between the CT and TH patients. (D) The microbial type distribution was compared between the C-CT, S-CT, C-TH, and S-TH groups.

Certain bacteria, especially from the surface tonsils, help distinguish CT patients from TH patients.

As many as 12 different genera were identified as significantly different in their proportions when comparing the tonsillar tissues of the CT and TH patients (Fig. 4A). Of these, Dialister, Parvimonas, Bacteroidales [G-2], Aggregatibacter, and Atopobium, from the tonsillar tissues of the CT patients, and Haemophilus, Streptococcus, Neisseria, Capnocytophaga, Kingella, Moraxella, and Lachnospiraceae [G-2], from the tonsillar tissues of the TH patients, were significantly higher than those of the other group of patients (Fig. 4A).

FIG 4.

FIG 4

Differential genera identified in the comparison between tonsillar (core tonsil and surface tonsil) tissues from the CT and TH patients. (A) Differential genera selected from the comparison between patient groups of CT and TH patients. (B) Differential genera selected from the comparison between the tissues collected from the core and surface tonsils of the CT patients. (C) Differential genera selected from the comparison between the tissues collected from the core and surface tonsils of the TH patients. (D) Differential genera selected from the comparison between the tissues collected from the core tonsils of the CT and TH patients. (E) Differential genera selected from the comparison between the tissues collected from the surface tonsils of the CT and TH patients. Differential genera with a relative abundance of more than 1% and false discovery rate (FDR) of <0.05 were selected using multiple comparisons of the Mann-Whitney U test with a Benjamini-Hochberg adjustment. *, FDR < 0.05; **, FDR < 0.01; ***, FDR < 0.001.

Further analysis of the groups (C-CT, S-CT, C-TH, and S-TH) showed that most of the differences between CT and TH patients were also observed by comparing only the surface microbiota (Fig. 4B to E). A significantly larger amount of Streptococcus was found in the core tissues of the TH patients than in the core tissues of the CT patients (Fig. 4D). Furthermore, as shown in Fig. 4E, when comparing the S-CT with the S-TH group, a higher level of Bacteroidales [G-2], Dialister, Parvimonas, Aggregatibacter, and Atopobium from the surface tonsillar tissues of the CT patients and a higher level of Haemophilus, Neisseria, Capnocytophaga, Kingella, and Lachnospiraceae [G-2] from the surface tonsillar tissues of the TH patients were observed. Comparisons among other groups did not reveal substantial microbial differences (Fig. 4B and C).

At the species level, significantly higher levels of Parvimonas micra, Bacteroidales [G-2] bacterium HMT 274, Dialister invisus, Atopobium rimae, and Catonella morbi in the CT patients and Haemophilus influenzae, Streptococcus pyogenes, Neisseria flavescens, Kingella sp. strain HMT 012, Campylobacter rectus, Capnocytophaga sputigena, Lachnospiraceae [G-2] bacterium HMT 088, and Prevotella nanceiensis in the TH patients were detected (Fig. S3A). Similar to what was observed at the genus level, most of the differences could be observed from the surface tissues of the CT and TH patients, while the other comparisons had much less bacterial difference (Fig. S3B to E).

FIG S3

Identified differential species when the tonsillar (core tonsil and surface tonsil) tissues from CT and TH patients were compared. (A) Differential species selected from the comparison between CT and TH patients. (B) Differential species selected from the comparison between tissues collected from the core and surface tonsils of the CT patients. (C) Differential species selected from the comparison between the tissues collected from the core and surface tonsils of the TH patients. (D) Differential species selected from the comparison between the tissues collected from the core tonsils of the CT and TH patients. (E) Differential species selected from the comparison between the tissues collected from the surface tonsils of the CT and TH patients. Differential genera with a relative abundance of more than 1% and false discovery rate of <0.05 were selected using multiple comparisons of the Mann-Whitney U test with a Benjamini-Hochberg adjustment. *, FDR < 0.05; **, FDR < 0.01; ***, FDR < 0.001. Download FIG S3, PDF file, 2.9 MB (443.6KB, pdf) .

Copyright © 2021 Wu et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

The bacteria differed between CT and TH patients and served various functions.

From the network generated based on all the genera and the degree centrality, closeness centrality, and betweenness centrality of each genus, bacteria that had significantly different proportions between CT and TH patients, such as Dialister, Parvimonas, and Neisseria, were located at key positions in the microbiota network (Fig. 5A, Table S2). This indicates that, apart from distinguishing CT patients from HT ones, the identified bacteria also serve core functions in the microbiota network. Furthermore, Fig. 5A shows that the majority of the correlation was positively related, indicating that the abundance alteration of these key genera positively affected the other bacteria in the tonsillar microbiota network.

FIG 5.

FIG 5

Identification of the tonsillar microbial network and potential drug resistance and immune function-related pathways. (A) The correlation among genera in tonsillar tissues based on Spearman's rank correlation coefficient analysis (correlation coefficient >0.5 and p < 0.05). The numbers on the nodes represent the rank of top 10 key genera based on the calculated degree centrality, closeness centrality, and betweenness centrality. The red line represents the positive correlation, and the green line represents the negative correlation. (B) The identified different drug resistance- and immune function-related pathways based on the predicted metagenome comparison of tonsillar tissues from CT and TH patients. *, FDR < 0.05; **, FDR < 0.01. (C) The correlation between significantly altered pathways and genera. Only Spearman's rank correlation coefficient of >0.5 and FDR of <0.05 are presented. The red grid indicates the positive correlation, and the green grid indicates the negative correlation. **, FDR < 0.01; ***, FDR < 0.001.

TABLE S2

Identification of key genera based on calculated degree centrality, closeness centrality, and betweenness centrality using Python package “NetworkX”. Download Table S2, DOCX file, 0.01 MB (13.8KB, docx) .

Copyright © 2021 Wu et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Different drug resistance (antimicrobial and antineoplastic) and immune pathways were further analyzed. Significantly higher beta-lactam resistance and increased retinoic acid-inducible gene I (RIG-I)-like receptor signaling pathways were observed in the TH patients, while an increase of Toll/Imd signaling pathways was observed in the CT patients (Fig. 5B). Furthermore, Neisseria, which was significantly increased in TH patients, was also correlated with an increased RIG-I-like receptor signaling pathway and beta-lactam resistance in the TH patients. Parvimonas and Atopobium, which were significantly increased in CT patients, were correlated with a higher beta-lactam resistance (Fig. 5C). In addition, Dialister, which was increased in the CT patients, was negatively correlated with the RIG-I-like receptor signaling pathway (Fig. 5C).

DISCUSSION

In this study, we have demonstrated the microbial differences between surface and core tonsillar tissue and their relation to CT and TH diseases using microbiome 16S rRNA gene sequencing. Our data indicated a comparable bacterial alpha diversity of tonsillar microbiota from CT and TH patients. However, the microbial communities present in the tonsillar tissues of CT patients are different from those in TH patients, especially the ones on the surface of the tonsils. We proposed four different tonsillar microbial types and certain bacterial genera/species that could distinguish CT patients from TH patients. Furthermore, the key players in the microbiota and bacterial functions have also been investigated.

Our study used surgically removed tonsillar samples, which provided more material than tonsillar swabs and allowed us to compare surface tissues with core tissues. The culture-independent sequencing techniques could also draw a complete picture of microbiota in tonsils, especially for the unculturable bacteria. Moreover, by using the expanded Human Oral Microbiome Database (eHOMD) to identify the tonsillar genera, we found a relatively high abundance of Haemophilus, Streptococcus, Neisseria, Capnocytophaga, Kingella, Moraxella, and Lachnospiraceae [G-2] in patients with TH and Dialister, Parvimonas, Bacteroidales [G-2], Aggregatibacter, and Atopobium in patients with CT (Fig. 4). These identified genera are consistent with earlier studies on tonsillar microbiota. One study with recurrent tonsillitis (RT) participants showed a high relative abundance of Parvimonas, while patients with obstructive sleep apnea (OSA) had a high relative abundance of Haemophilus and Capnocytophaga (8). Other studies have also identified that patients with OSA or TH have a higher relative abundance of Haemophilus (7) and Streptococcus (12) than RT patients. Moreover, the main species of Moraxella (13) and Neisseria (9) have also proven to be positively correlated with the occurrence of TH in previous research. Dialister (14), Aggregatibacter (15), and Atopobium (16), which were present significantly more in CT patients, have been demonstrated to be increased in several infective and inflammation-related diseases, including acute tonsillitis (16). Notably, Haemophilus and Neisseria, which have higher abundance in tonsillar microbiota type 3, were significantly increased in the TH patients, highlighting the potential role of these bacteria in the occurrence of TH (8, 9).

Of the significantly different species among the compared groups, Haemophilus influenzae and Streptococcus pyogenes have been more frequently observed among TH patients than CT patients (6). Additionally, Bacteroidales [G-2] bacterium HMT 274 (17), Campylobacter rectus (18), Capnocytophaga sputigena (19), Atopobium rimae (20), and Dialister invisus (21) were previously identified as commensals involved in oral infections. All these results indicate that the presented bacteria serve as biomarkers for the identification of TH and CT.

Antimicrobial resistance has become a concern and threat to health benefits, reflecting the worldwide abuse of antibiotics. Whether the resistance predicted in this study is related to intrinsic resistance or antibiotic treatment should be further considered (22). Furthermore, several bacteria found in this study have been shown to correlate with pathogenicity and inflammation in tonsillitis (23). The immune response to acute tonsillitis-related microbes has also been reported (24). Toll-like receptors (TLRs) and RIG-I-like receptors (RLRs) are the key innate immune pattern recognition receptors and are regulated by elaborate mechanisms to ensure a beneficial outcome in response to pathogens (25). Significantly increased RLR signaling pathways and TLR pathways were observed in the TH and CT patients, respectively. This indicates that the differential bacterial composition of TH and CT patients activate different immune signaling pathways. Notably, bacteria such as Neisseria, which was enriched in the TH patients and triggers the RIG-I-like receptor signaling pathway, may serve as the key pathogenesis player for TH development. Further studies, especially longitudinal studies, are needed to illuminate the role and mechanism of the differential species in regulating the occurrence of different diseases.

There are several limitations to the present study. First, although significant differences between the patient groups were identified, this is a small cohort of patients, which must be taken into account when interpreting the data. Additionally, exposure to antibiotics affects microbiota, at least in the short or medium term. The patients’ history of antibiotic use was unknown, which also indicates that our microbiota findings might be influenced by different drugs administered before tonsillectomy. Furthermore, taxonomic classification is not very reliable at the species level, amplifying part of the 16S rRNA gene (V3-V4 regions) (26), and the use of phylogenetic investigation of communities by the reconstruction of unobserved states 2 (PICRUSt2) could not reflect the actual metagenome and microbial function changes. However, using PICRUSt2 could provide new microbial insights to search for potential biomarkers or treatment targets for CT or TH patients (27). Moreover, given that most of the identified differential genera in our study were also previously identified between CT and TH patients using swab samples (79), we believe that our results provide valuable information for further studies to use, especially the bacteria we found to be related to CT versus TH and core versus surface tissues. Longitudinal studies that are focused on the metagenome and that use information on factors that influence microbiota, such as antibiotic exposure and eating habits, will provide further understanding on tonsillar microbiota.

Conclusions.

To summarize, we have demonstrated that significant levels of differential microbiota are present in the core and surface tonsillar tissues of CT and TH patients. Further, our results indicated that several identified genera, such as Haemophilus, Neisseria, Dialister, and Parvimonas, could be used as potential biomarkers and have a role in the pathogenesis of diseases.

MATERIALS AND METHODS

Study design, population, and sample collection.

This was a cross-sectional study involving patients who were operated upon for tonsillectomy between May and October 2015 at four ear, nose, and throat (ENT) clinics in Stockholm, Sweden. The CT and TH patients were diagnosed according to the Paradise’s (28) and Brodsky’s criteria (29). Patients with other otolaryngologic problems or systemic disorders were excluded. A total of 22 tonsils (both left and right sides) were removed and collected from 5 CT and 6 TH patients and directly snap-frozen at −80°C until further DNA extraction. Patients who had symptoms of recurrent acute tonsillitis (defined as multiple episodes of tonsillitis for more than 2 years), foul-smelling mouth, and recurrent sore throat were considered CT. The patients who had obstructive symptoms, such as breathing difficulties, swallowing problems, snoring, and enlarged tonsils, were considered TH. There were no tonsillar infection problems and no history of recurrent tonsillitis in the TH group. Detailed information about these patients is listed in Table 1. Participation in the study was voluntary, and informed consent was obtained before surgery. The study was approved by the Regional Ethical Board at Karolinska Institutet, Stockholm, Sweden.

DNA extraction.

Both the surface and core tissues (around 0.5 cm by 0.5 cm in size) from each tonsil were cut and collected in a sterile environment. As shown in Fig. S1A in the supplemental material, there is a distinct boundary between the surface and core tissues of tonsils. The surface tissue of each tonsil was gathered, and then the tonsillar samples were prudently and sagitally sectioned into two parts, followed by the collection of the core tissues. Scalpels were changed between collection of surface and core tissues and between samples in a biosafety cabinet.

Tonsillar tissues (n = 44) were bead-beaten with Matrix E beads (MP Biomedicals, USA) for three 2-min cycles. The tissues were then incubated with 20 μl of lysozyme (100 mg/ml) at 37°C for 60 min, followed by digestion with 20 μl proteinase K (20 mg/ml) for 90 min at 55°C, 250 rpm. The purification was performed with TECAN Fredom EVO with the Quick DNA Magbead Plus kit (D4082; Zymo Research, USA), according to the manufacturer’s guidelines and our previous study (30, 31). During the DNA extraction process, DNA/RNA Shield and ZymoBIOMICS Microbial Community Bacterial Standard (D6300; Zymo Research, USA) were used as the negative and positive extraction controls, respectively. The final DNA concentration and purification were determined by fluorometry using a Qubit 2.0 fluorometer (Life Technologies, NY, USA). The purified DNA was stored at −80°C until further microbiota sequencing.

Microbiota sequencing and analysis.

The V3-V4 regions of the 16S rRNA genes were amplified with Illumina sequencing index-binding primer pair 341F/805R using a previously established automated pipeline (31). For library preparation, DNA-free water and ZymoBIOMICS Microbial Community DNA Standard (D6305; Zymo Research, USA) were included as the negative and positive PCR controls. Meanwhile, both negative and positive controls from the extraction phase were also submitted to PCR as the negative and positive controls. Two (the core tissues of right tonsils of patients 1 and 3) of 44 sample libraries with concentrations less than 2 nM were discarded (Table 1). Thereafter, paired-end sequences (2 × 300 bp) of 42 prepared sample libraries and controls from the DNA extraction and PCR steps were generated on an Illumina MiSeq sequencing platform (Illumina, CA, USA) with MiSeq reagent kit v3 (Illumina).

Bioinformatics analysis.

A power analysis of the sample size for 16S rRNA gene sequencing was performed using a microbiome power calculator (32). With a false discovery rate (FDR) of 5% for multiple testing corrections, the simulation results demonstrated that the 42 sequencing samples had a sufficient power of 0.8 to detect significant differences in community diversity.

Raw fastq files were quality filtered and then merged together using Trimmomatic (33) and FLASH (34). Briefly, the reads were deleted if they were less than 50 bp in length or received an average quality score of <20 over a 50-bp sliding window. Sequences were merged if the overlap was longer than 10 bp and the mismatch less than 2 bp. Reads were further removed when containing ambiguous bases.

A greedy algorithm using UPARSE (version 7.1; http://drive5.com/uparse/) that performs chimera filtering and OTU clustering simultaneously was applied (35). OTUs were clustered with 97% similarity. The OTUs with abundance lower than the negative controls were excluded for further analysis. The taxonomy of each OTU was analyzed by an RDP Classifier algorithm (http://rdp.cme.msu.edu/) against the eHOMD (V15.2) database (36) with a confidence threshold of 0.7. Different taxonomies were determined at the phylum, class, order, family, genus, and species levels for all the sequenced samples.

The analysis on alpha and beta diversity was performed on the filtered data using USEARCH alpha_div (37) and UniFrac metrics (38) in QIIME (version 1.9.1) (39), respectively. In detail, species OTU richness estimates (Chao1 and ACE) and diversity index (Simpson) were carried out for microbiota alpha diversity from all the samples. Beta diversity from different samples was compared via nonmetric multidimensional scaling (NMDS) analysis based on Bray-Curtis distance matrices. In addition, a permutational multivariate analysis of variance (PERMANOVA) with treatments (surface and core tonsils of CT and TH patients) and three covariates (age, gender, and heterogeneity of left/right tonsil tissues) were performed to compare the contribution of treatments and each covariate to the microbiota difference. Furthermore, partitioning around medoids (PAM) clustering was performed based on the Jensen-Shannon divergence (JSD). The best clustering K number was calculated using the Calinski-Harabasz (CH) index (40). The tonsillar microbial types were analyzed using between-class analysis (BCA) (K ≥ 3) and visualized by principal coordinate analysis (PCoA) (K ≥ 2).

Network graphs were calculated based on the correlation of the abundance of all the tested genera using the Python package NetworkX and visualized in Cytoscape (v3.4.0) (41, 42). Degree centrality, closeness centrality, and betweenness centrality were calculated and ranked (41, 43). The phylogenetic investigation of communities by the reconstruction of unobserved states 2 (PICRUSt2) analysis (https://github.com/picrust/picrust2) (27) was used to predict the metagenome in the samples and predict the bacterial drug resistance- and immune function-related pathways using the Kyoto Encyclopedia of Genes and Genomes (KEGG) orthologs (KEGG hierarchical level 3) (44).

Statistics.

The Mann-Whitney U test was performed to compare the microbial alpha diversity of CT and TH. The Kruskal-Wallis test with Dunn’s post hoc test was employed to test microbial alpha diversity differences between C-CT, S-CT, C-TH, and S-TH. ANOSIM analysis based on Bray-Curtis distance matrices was used to identify the beta diversity between two or more compared groups. In addition, the Adonis function from the R package vegan was used for PERMANOVA (45, 46). The Mann-Whitney U test was used with multiple comparisons adjusted by the Benjamini-Hochberg FDR to rank bacteria that were significantly different in their genus/species levels and for drug resistance pathway analysis. Pairwise correlations (p < 0.05; Spearman's rank correlation coefficient >0.5) were used to generate genus-level cooccurrence networks.

Data availability.

All the data generated or analyzed for this study are included in this paper. The sequencing reads are available in the Sequence Read Archive (SRA) of NCBI under accession project number PRJNA633894.

ACKNOWLEDGMENTS

We thank Justine Debelius for great advice on bioinformatics analysis and Nagihan Bostanci and Per Hydbring for critically reading the manuscript. We especially thank two anonymous reviewers for valuable suggestions and comments to improve this study.

Conception and design: L.H.N., M.J., L.E., J.D., and A.T. Sample collection: L.H.N., M.J., and A.T. Development of methodology: S.W., L.C., S.A.R., P.A., Y.Z.G., M.H., and J.D. Acquisition of data: S.W., L.C., S.A.R., P.A., Y.Z.G., M.H., and J.D. Analysis and interpretation of data: S.W., L.H.N., J.D., and A.T. Writing, review, and/or revision of the manuscript: S.W., L.H.N., J.D., and A.T., together with all authors.

J.D. and S.W. were supported by The Swedish Foundation for Strategic Research (SSF) [ICA16-0050], Åke Wibergs Foundation [M18-0112], Jeanssons Foundation [JS2018-0034], Clas Groschinskys Minnesfond [M18213, M19351], and Karolinska Institute. Ferring Pharmaceuticals funded the center where this project was carried out.

We declare that we have no competing or commercial interests.

Contributor Information

Juan Du, Email: juan.du@ki.se.

Naseer Sangwan, Cleveland Clinic.

REFERENCES

  • 1.Man WH, de Steenhuijsen Piters WA, Bogaert D. 2017. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol 15:259–270. doi: 10.1038/nrmicro.2017.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mikola E, Elenius V, Saarinen M, Palomares O, Waris M, Turunen R, Puhakka T, Ivaska L, Rückert B, Aab A, Vahlberg T, Vuorinen T, Allander T, Camargo CA, Jr, Akdis M, Akdis CA, Jartti T. 2018. Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis. Clin Transl Allergy 8:22. doi: 10.1186/s13601-018-0205-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Önal M, Yılmaz T, Bilgiç E, Müftüoğlu SF, Kuşçu O, Günaydın RÖ. 2015. Apoptosis in chronic tonsillitis and tonsillar hypertrophy. Int J Pediatr Otorhinolaryngol 79:191–195. doi: 10.1016/j.ijporl.2014.12.005. [DOI] [PubMed] [Google Scholar]
  • 4.Chen S, Wang WW, Wang Y, Li YQ, Zhu LX. 2020. Cellular senescence in recurrent tonsillitis and tonsillar hypertrophy in children. Int J Pediatr Otorhinolaryngol 133:110004. doi: 10.1016/j.ijporl.2020.110004. [DOI] [PubMed] [Google Scholar]
  • 5.Lopez-Gonzalez MA, Sanchez B, Mata F, Delgado F. 1998. Tonsillar lymphocyte subsets in recurrent acute tonsillitis and tonsillar hypertrophy. Int J Pediatr Otorhinolaryngol 43:33–39. doi: 10.1016/s0165-5876(97)00148-1. [DOI] [PubMed] [Google Scholar]
  • 6.Jeong JH, Lee DW, Ryu RA, Lee YS, Lee SH, Kang JO, Tae K. 2007. Bacteriologic comparison of tonsil core in recurrent tonsillitis and tonsillar hypertrophy. Laryngoscope 117:2146–2151. doi: 10.1097/MLG.0b013e31814543c8. [DOI] [PubMed] [Google Scholar]
  • 7.Wang Q, Du J, Jie C, Ouyang H, Luo R, Li W. 2017. Bacteriology and antibiotic sensitivity of tonsillar diseases in Chinese children. Eur Arch Otorhinolaryngol 274:3153–3159. doi: 10.1007/s00405-017-4603-y. [DOI] [PubMed] [Google Scholar]
  • 8.Johnston J, Hoggard M, Biswas K, Astudillo-García C, Waldvogel-Thurlow S, Radcliff FJ, Mahadevan M, Douglas RG. 2018. The bacterial community and local lymphocyte response are markedly different in patients with recurrent tonsillitis compared to obstructive sleep apnoea. Int J Pediatr Otorhinolaryngol 113:281–288. doi: 10.1016/j.ijporl.2018.07.041. [DOI] [PubMed] [Google Scholar]
  • 9.Jensen A, Fagö-Olsen H, Sørensen CH, Kilian M. 2013. Molecular mapping to species level of the tonsillar crypt microbiota associated with health and recurrent tonsillitis. PLoS One 8:e56418. doi: 10.1371/journal.pone.0056418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Johnston J, Hoggard M, Biswas K, Astudillo-García C, Radcliff FJ, Mahadevan M, Douglas RG. 2018. Paired analysis of the microbiota between surface tissue swabs and biopsies from pediatric patients undergoing adenotonsillectomy. Int J Pediatr Otorhinolaryngol 113:51–57. doi: 10.1016/j.ijporl.2018.07.024. [DOI] [PubMed] [Google Scholar]
  • 11.Khadilkar MN, Ankle NR. 2016. Anaerobic bacteriological microbiota in surface and core of tonsils in chronic tonsillitis. J Clin Diagn Res 10:MC01–MC03. doi: 10.7860/JCDR/2016/22124.8819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Pontin IPO, Sanchez DCJ, Di Francesco R. 2016. Asymptomatic group A streptococcus carriage in children with recurrent tonsillitis and tonsillar hypertrophy. Int J Pediatr Otorhinolaryngol 86:57–59. doi: 10.1016/j.ijporl.2016.03.044. [DOI] [PubMed] [Google Scholar]
  • 13.Prates M, Tamashiro E, Proenca-Modena JL, Criado MF, Saturno TH, Oliveira AS, Buzatto GP, Jesus BLS, Jacob MG, Carenzi LR, Demarco RC, Massuda ET, Aragon D, Valera FCP, Arruda E, Anselmo-Lima WT. 2018. The relationship between colonization by Moraxella catarrhalis and tonsillar hypertrophy. Can J Infect Dis Med Microbiol 2018:5406467. doi: 10.1155/2018/5406467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wang Y, Zhang J, Chen X, Jiang W, Wang S, Xu L, Tu Y, Zheng P, Wang Y, Lin X, Chen H. 2017. Profiling of oral microbiota in early childhood caries using single-molecule real-time sequencing. Front Microbiol 8:2244. doi: 10.1155/2018/5406467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Garlet GP, Cardoso CR, Campanelli AP, Garlet TP, Avila-Campos MJ, Cunha FQ, Silva JS. 2008. The essential role of IFN-γ in the control of lethal Aggregatibacter actinomycetemcomitans infection in mice. Microbes Infect 10:489–496. doi: 10.1016/j.micinf.2008.01.010. [DOI] [PubMed] [Google Scholar]
  • 16.Yeoh YK, Chan MH, Chen Z, Lam EW, Wong PY, Ngai CM, Chan PKS, Hui M. 2019. The human oral cavity microbiota composition during acute tonsillitis: a cross-sectional survey. BMC Oral Health 19:275. doi: 10.1186/s12903-019-0956-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Li CL, Liang JP, Jiang YT. 2006. Association of uncultivated oral phylotypes AU126 and X112 with periodontitis. Oral Dis 12:371–374. doi: 10.1111/j.1601-0825.2005.01205.x. [DOI] [PubMed] [Google Scholar]
  • 18.Mahlen SD, Clarridge JE. 2009. Oral abscess caused by Campylobacter rectus: case report and literature review. J Clin Microbiol 47:848–851. doi: 10.1128/JCM.01590-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kim YJ, Choi YS, Baek KJ, Yoon SH, Park HK, Choi Y. 2016. Mucosal and salivary microbiota associated with recurrent aphthous stomatitis. BMC Microbiol 16:57. doi: 10.1186/s12866-016-0673-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.George N, Flamiatos E, Kawasaki K, Kim N, Carriere C, Phan B, Joseph R, Strauss S, Kohli R, Choi D, Baumgartner JC, Sedgley C, Maier T, Machida CA. 2016. Oral microbiota species in acute apical endodontic abscesses. J Oral Microbiol 8:30989. doi: 10.3402/jom.v8.30989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Rôças IN, Siqueira JF, Jr.. 2005. Detection of novel oral species and phylotypes in symptomatic endodontic infections including abscesses. FEMS Microbiol Lett 250:279–285. doi: 10.1016/j.femsle.2005.07.017. [DOI] [PubMed] [Google Scholar]
  • 22.Alasmari NSH, Bamashmous ROM, Alshuwaykan RMA, Alahmari MAM, Alshahrani AAM, Alqarni SA, Alamri SOR. 2017. Causes and treatment of tonsillitis. Egyptian J Hosp Med 69:2975–2980. doi: 10.12816/0042838. [DOI] [Google Scholar]
  • 23.Brook I. 2005. The role of anaerobic bacteria in tonsillitis. Int J Pediatr Otorhinolaryngol 69:9–19. doi: 10.1016/j.ijporl.2004.08.007. [DOI] [PubMed] [Google Scholar]
  • 24.Brook I, Foote PA, Slots J. 1997. Immune response to Fusobacterium nucleatum, Prevotella intermedia and other anaerobes in children with acute tonsillitis. J Antimicrob Chemother 39:763–769. doi: 10.1093/jac/39.6.763. [DOI] [PubMed] [Google Scholar]
  • 25.Martínez I, Oliveros JC, Cuesta I, de la Barrera J, Ausina V, Casals C, de Lorenzo A, García E, García-Fojeda B, Garmendia J, González-Nicolau M, Lacoma A, Menéndez M, Moranta D, Nieto A, Ortín J, Pérez-González A, Prat C, Ramos-Sevillano E, Regueiro V, Rodriguez-Frandsen A, Solís D, Yuste J, Bengoechea JA, Melero JA. 2017. Apoptosis, Toll-like, RIG-I-like and NOD-like receptors are pathways jointly induced by diverse respiratory bacterial and viral pathogens. Front Microbiol 8:276. doi: 10.3389/fmicb.2017.00276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Johnson JS, Spakowicz DJ, Hong BY, Petersen LM, Demkowicz P, Chen L, Leopold SR, Hanson BM, Agresta HO, Gerstein M, Sodergren E, Weinstock GM. 2019. Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat Commun 10:5029. doi: 10.1038/s41467-019-13036-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, Huttenhower C, Langille MGI. 2020. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol 38:685–688. doi: 10.1038/s41587-020-0548-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Paradise JL, Bluestone CD, Colborn DK, Bernard BS, Rockette HE, Kurs-Lasky M. 2002. Tonsillectomy and adenotonsillectomy for recurrent throat infection in moderately affected children. Pediatrics 110:7–15. doi: 10.1542/peds.110.1.7. [DOI] [PubMed] [Google Scholar]
  • 29.Brodsky L. 1989. Modern assessment of tonsils and adenoids. Pediatr Clin North Am 36:1551–1569. doi: 10.1016/s0031-3955(16)36806-7. [DOI] [PubMed] [Google Scholar]
  • 30.Ährlund-Richter A, Cheng L, Hu YOO, Svensson M, Pennhag AAL, Ursu RG, Haeggblom L, Grün N, Ramqvist T, Engstrand L, Dalianis T, Du J. 2019. Changes in cervical human papillomavirus (HPV) prevalence at a youth clinic in stockholm, sweden, a decade after the introduction of the HPV vaccine. Front Cell Infect Microbiol 9:59. doi: 10.3389/fcimb.2019.00059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Hugerth LW, Seifert M, Pennhag AA, Du J, Hamsten MC, Schuppe-Koistinen I, Engstrand L. 2018. A comprehensive automated pipeline for human microbiome sampling, 16S rRNA gene sequencing and bioinformatics processing. bioRxiv doi: 10.1101/286526. [DOI]
  • 32.Mattiello F, Verbist B, Faust K, Raes J, Shannon WD, Bijnens L, Thas O. 2016. A web application for sample size and power calculation in case-control microbiome studies. Bioinformatics 32:2038–2040. doi: 10.1093/bioinformatics/btw099. [DOI] [PubMed] [Google Scholar]
  • 33.Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114–2120. doi: 10.1093/bioinformatics/btu170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Magoč T, Salzberg SL. 2011. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27:2957–2963. doi: 10.1093/bioinformatics/btr507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Edgar RC. 2013. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 10:996–998. doi: 10.1038/nmeth.2604. [DOI] [PubMed] [Google Scholar]
  • 36.Escapa IF, Chen T, Huang Y, Gajare P, Dewhirst FE, Lemon KP. 2018. New insights into human nostril microbiome from the Expanded Human Oral Microbiome Database (eHOMD): a resource for the microbiome of the human aerodigestive tract. mSystems 3:e00187-18. doi: 10.1128/mSystems.00187-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Edgar RC. 2010. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26:2460–2461. doi: 10.1093/bioinformatics/btq461. [DOI] [PubMed] [Google Scholar]
  • 38.Lozupone C, Knight R. 2005. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 71:8228–8235. doi: 10.1128/AEM.71.12.8228-8235.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7:335–336. doi: 10.1038/nmeth.f.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto J-M, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Doré J, Antolín M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, Dervyn R, MetaHIT Consortium , et al. 2011. Enterotypes of the human gut microbiome. Nature 473:174–180. doi: 10.1038/nature09944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Hagberg AA, Schult DA, Swart PJ. 2008. Exploring network structure, dynamics, and function using NetworkX, p 11–15. In Varoquaux G, Vaught T, Millman J (ed), Proc 7th Python Sci Conf (SciPy2008). SciPy Organizers, Pasadena, CA. [Google Scholar]
  • 42.Gomez A, Espinoza JL, Harkins DM, Leong P, Saffery R, Bockmann M, Torralba M, Kuelbs C, Kodukula R, Inman J, Hughes T, Craig JM, Highlander SK, Jones MB, Dupont CL, Nelson KE. 2017. Host genetic control of the oral microbiome in health and disease. Cell Host Microbe 22:269–278. doi: 10.1016/j.chom.2017.08.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Paropkari AD, Leblebicioglu B, Christian LM, Kumar PS. 2016. Smoking, pregnancy and the subgingival microbiome. Sci Rep 6:30388. doi: 10.1038/srep30388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. 2004. The KEGG resource for deciphering the genome. Nucleic Acids Res 32:D277–D280. doi: 10.1093/nar/gkh063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Mandal S, Van Treuren W, White RA, Eggesbo M, Knight R, Peddada SD. 2015. Analysis of composition of microbiomes: a novel method for studying microbial composition. Microb Ecol Health Dis 26:27663. doi: 10.3402/mehd.v26.27663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA, Molho E, Zabetian CP, Knight R, Payami H. 2017. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Mov Disord 32:739–749. doi: 10.1002/mds.26942. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

FIG S1

Comparison of tonsillar (core tonsil and surface tonsil) microbial alpha diversity (ACE and Chao1 indices) in chronic tonsillitis (CT) and tonsillar hypertrophy (TH) patients. (A) Image of a lanced tonsil. The core and surface tissue areas are shown with yellow dotted lines. The sample site from core tissue is presented with a red dotted line, and the sample site from surface tissue is presented with a blue dotted line. (B) The microbial alpha diversity (ACE and Chao1 indices) in CT and TH patients was compared. The Mann-Whitney U test was carried out for comparing the two groups. (B) The microbial alpha diversity (ACE and Chao1 indices) in four groups, the core tonsil of chronic tonsillitis patients (C-CT), the surface tonsil of chronic tonsillitis patients (S-CT), the core tonsil of tonsillar hypertrophy patients (C-TH), and the surface tonsil of tonsillar hypertrophy patients (S-TH), was compared. Kruskal-Wallis test with Dunn’s post hoc tests was performed to compare all the groups. All the data are presented as mean ± standard deviation (SD) OTU counts. *, p < 0.05. Download FIG S1, PDF file, 0.1 MB (130KB, pdf) .

Copyright © 2021 Wu et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S1

Different microbial composition of core or surface tonsils from chronic tonsillitis (CT) or tonsillar hypertrophy (TH) patients based on a permutational multivariate analysis of variance (PERMANOVA). Download Table S1, DOCX file, 0.02 MB (20.6KB, docx) .

Copyright © 2021 Wu et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

FIG S2

Comparison of the tonsillar (core tonsil and surface tonsil) microbial communities at the species level in CT and TH patients. (A) The microbial species in the CT and TH patients were compared. (B) The microbial species in the C-CT, S-CT, C-TH, and S-TH groups were compared. Only species abundance of more than 1% are listed in panels A and B. Download FIG S2, TIF file, 2.8 MB (2.8MB, tif) .

Copyright © 2021 Wu et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

FIG S3

Identified differential species when the tonsillar (core tonsil and surface tonsil) tissues from CT and TH patients were compared. (A) Differential species selected from the comparison between CT and TH patients. (B) Differential species selected from the comparison between tissues collected from the core and surface tonsils of the CT patients. (C) Differential species selected from the comparison between the tissues collected from the core and surface tonsils of the TH patients. (D) Differential species selected from the comparison between the tissues collected from the core tonsils of the CT and TH patients. (E) Differential species selected from the comparison between the tissues collected from the surface tonsils of the CT and TH patients. Differential genera with a relative abundance of more than 1% and false discovery rate of <0.05 were selected using multiple comparisons of the Mann-Whitney U test with a Benjamini-Hochberg adjustment. *, FDR < 0.05; **, FDR < 0.01; ***, FDR < 0.001. Download FIG S3, PDF file, 2.9 MB (443.6KB, pdf) .

Copyright © 2021 Wu et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S2

Identification of key genera based on calculated degree centrality, closeness centrality, and betweenness centrality using Python package “NetworkX”. Download Table S2, DOCX file, 0.01 MB (13.8KB, docx) .

Copyright © 2021 Wu et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Data Availability Statement

All the data generated or analyzed for this study are included in this paper. The sequencing reads are available in the Sequence Read Archive (SRA) of NCBI under accession project number PRJNA633894.


Articles from mSystems are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES